+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Revascularization Device Market - Global Forecast 2026-2032- Product Image
Revascularization Device Market - Global Forecast 2026-2032- Product Image
Sale

Revascularization Device Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120779
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Revascularization Device Market is projected to reach USD 2.83 Billion in 2026. It is expected to continue growing at a CAGR of 10.30%, reaching USD 5.12 Billion by 2032.

Revascularization Devices: Executive Summary

Revascularization devices support the restoration of blood flow through diseased or obstructed vessels. They are used across coronary, peripheral, and neurovascular care, with clinical selection shaped by anatomy, disease severity, procedural risk, operator expertise, and local treatment pathways. Key device categories include stents, balloons, atherectomy systems, thrombectomy systems, grafts, and related delivery technologies. Adoption is closely linked to the burden of atherosclerotic disease, access to interventional services, diagnostic capabilities, reimbursement conditions, and evidence supporting safety and durability.

Clinical Complexity and Less-Invasive Care Are Reshaping Device Use

The landscape is shifting toward less-invasive treatment, more precise lesion assessment, and individualized procedural planning. Improvements in imaging, guidewires, catheters, stent platforms, drug-delivery technologies, and thrombectomy systems are expanding the ability to treat complex lesions while supporting shorter recovery times than many open procedures. At the same time, clinicians are placing greater emphasis on long-term outcomes, bleeding risk, restenosis, vessel preservation, and the durability of treatment. These priorities favor technologies that integrate effectively into multidisciplinary care and demonstrate consistent performance across varied patient anatomies.

Artificial Intelligence Is Strengthening Planning, Workflow, and Follow-Up

Artificial intelligence is increasingly relevant to revascularization through image interpretation, anatomical segmentation, lesion assessment, procedural planning, and workflow support. Algorithms can help identify suspected vascular disease, prioritize cases, quantify stenosis, and combine imaging or physiological data for more consistent decision-making. In catheterization and vascular suites, AI may support device selection, navigation assistance, radiation and contrast optimization, and post-procedure surveillance. Meaningful clinical value depends on representative training data, transparent validation, interoperability with hospital systems, cybersecurity, and clinician oversight. AI should augment-not replace-specialist judgment, particularly in complex or emergency procedures.

Regional Insights: Uneven Access Meets Broad Clinical Need

North America benefits from advanced interventional infrastructure, specialist availability, and established reimbursement pathways, while cost scrutiny and evidence requirements influence purchasing. Europe combines mature clinical practice with stringent regulatory, health-technology, and procurement expectations; differences among countries affect access and adoption. Asia-Pacific spans highly developed systems in countries such as Japan, Australia, and South Korea alongside rapidly expanding capacity in China and India, creating varied requirements for affordability, training, and local evidence. Latin America is shaped by public-private healthcare differences, import conditions, and concentration of specialist services. The Middle East is investing in tertiary and cardiovascular care, with adoption influenced by hospital modernization and workforce development. Africa continues to face substantial gaps in diagnosis, referral, specialist capacity, and device availability, making scalable care pathways and training especially important.

Group Insights: Economic and Institutional Alignment Shapes Access

ASEAN markets present diverse regulatory systems, healthcare resources, and levels of interventional expertise, favoring adaptable education and distribution models. BRICS countries combine large patient populations with differing reimbursement, manufacturing, procurement, and clinical infrastructure conditions; local production and value-based purchasing can be important considerations. The European Union emphasizes harmonized regulatory principles while retaining national differences in reimbursement and hospital procurement. G7 systems generally have mature specialist networks and strong evidence expectations, but face pressure to improve efficiency and manage aging populations. GCC countries are expanding advanced hospital capacity and often prioritize high-quality tertiary services, workforce development, and international clinical collaboration. NATO countries encompass varied healthcare systems, yet many share priorities around resilient supply chains, emergency preparedness, and continuity of critical medical care.

Country Insights: Diverse Systems Require Tailored Implementation

The United States combines extensive interventional capability with complex coverage, site-of-care, and evidence requirements. Canada’s publicly funded system places emphasis on clinical prioritization, capacity management, and provincial procurement. Mexico and Brazil must navigate regional disparities, public-private segmentation, and affordability constraints. The United Kingdom emphasizes evidence appraisal, centralized guidance, and pressure on elective and urgent-care capacity. France, Germany, Italy, and Spain have sophisticated specialist services, with adoption shaped by national reimbursement, hospital procurement, and regulatory implementation. Australia supports advanced vascular care across major centers while addressing geographic dispersion. China is expanding sophisticated cardiovascular and vascular services alongside localization and access priorities. India faces substantial disease burden and uneven access, encouraging cost-conscious innovation and broader specialist training. Japan emphasizes procedural quality, aging-population needs, and careful clinical evaluation. South Korea combines advanced hospitals with strong technology capabilities. Russia’s access is influenced by healthcare infrastructure, procurement conditions, and supply continuity.

Action Priorities for Leaders: Prove Value, Build Capability, and Secure Delivery

Industry leaders should align product development with clearly defined clinical problems, including complex anatomy, thrombotic emergencies, restenosis prevention, and treatment in patients at elevated procedural risk. Evidence programs should measure patient-relevant outcomes, procedural efficiency, safety, durability, and total care-pathway impact rather than relying solely on technical performance. Commercial strategies should segment markets by infrastructure, reimbursement, and specialist capacity, while supporting clinician training, simulation, proctoring, and post-market surveillance. Digital and AI capabilities should be introduced with robust validation, explainability, cybersecurity, and interoperability. Finally, organizations should strengthen supply-chain resilience, maintain regulatory readiness across jurisdictions, and collaborate with hospitals on pathway redesign, appropriate-use criteria, and equitable access.

Research Methodology: Evidence-Led Market Assessment

This executive summary applies a structured review of the revascularization-device landscape, organized around clinical applications, device categories, care pathways, technology trends, regional conditions, country systems, and institutional groupings. Insights should be validated against peer-reviewed clinical literature, regulatory publications, professional-society guidance, public health statistics, reimbursement policies, hospital procurement documentation, and disclosed post-market safety information. Comparative interpretation considers disease burden, diagnostic and procedural capacity, specialist workforce, infrastructure, affordability, regulatory requirements, and supply continuity. Artificial-intelligence observations are assessed separately for clinical relevance, data governance, validation quality, workflow integration, and human oversight. The approach intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons.

Conclusion: Durable Progress Depends on Evidence and Access

Revascularization devices remain central to contemporary management of obstructive vascular disease, but successful adoption depends on more than technical innovation. The strongest opportunities are associated with precise patient selection, minimally invasive treatment, reliable long-term outcomes, integrated imaging and decision support, and efficient multidisciplinary pathways. Regional and country differences make implementation highly context dependent, while group-level priorities highlight the importance of regulation, reimbursement, training, and supply resilience. Leaders that pair clinically meaningful innovation with transparent evidence, responsible AI governance, workforce development, and equitable access will be better positioned to improve outcomes across diverse healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Revascularization Device Market, by Product Type
7.1. Introduction
7.2. Atherectomy Devices
7.3. Balloon Angioplasty Catheters
7.4. Bare-Metal Stents
7.5. Drug-Coated Balloons
7.6. Drug-Eluting Stents
7.6.1. Everolimus-Eluting Stents
7.6.2. Paclitaxel-Eluting Stents
7.6.3. Sirolimus-Eluting Stents
7.6.4. Zotarolimus-Eluting Stents
7.7. Vascular Scaffolds
8. Revascularization Device Market, by Procedure Type
8.1. Introduction
8.2. Coronary Artery Bypass Grafting
8.3. Percutaneous Coronary Intervention
9. Revascularization Device Market, by Material
9.1. Introduction
9.2. Bioabsorbable Scaffold
9.3. Metallic
9.3.1. Cobalt-Chromium
9.3.2. Platinum-Chromium
9.3.3. Stainless Steel
9.4. Polymer
9.4.1. Bioresorbable Polymer
9.4.2. Non-Biodegradable Polymer
10. Revascularization Device Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Center
10.3. Hospital
10.4. Specialty Center
11. Revascularization Device Market, by Clinical Indication
11.1. Introduction
11.2. Acute Coronary Syndrome
11.3. Restenosis
11.4. Stable Coronary Artery Disease
12. Revascularization Device Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Revascularization Device Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Revascularization Device Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. AngioDynamics, Inc.
16.3. Asahi Intecc Co., Ltd.
16.4. B. Braun Melsungen AG
16.5. Becton, Dickinson and Company
16.6. Biotronik SE & Co. KG
16.7. Boston Scientific Corporation
16.8. Cardinal Health, Inc.
16.9. Cook Medical LLC
16.10. Edwards Lifesciences Corporation
16.11. Getinge AB
16.12. iVascular SLU
16.13. Johnson & Johnson
16.14. Lepu Medical Technology (Beijing) Co., Ltd
16.15. Medtronic plc
16.16. Merit Medical Systems, Inc.
16.17. MicroPort Scientific Corporation
16.18. OrbusNeich Medical Company Limited
16.19. Penumbra, Inc.
16.20. Stryker Corporation
16.21. Teleflex Incorporated
16.22. Terumo Corporation
16.23. W. L. Gore & Associates, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Revascularization Device Market, Years Considered for the Study
FIGURE 2. Global Revascularization Device Market, Research Design
FIGURE 3. Global Revascularization Device Market, Research Framework
FIGURE 4. Global Revascularization Device Market, Data Triangulation
FIGURE 5. Global Revascularization Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Revascularization Device Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Revascularization Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Revascularization Device Market Size, by Procedure Type, 2025 vs 2032 (%)
FIGURE 9. Global Revascularization Device Market Size, by Procedure Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Revascularization Device Market Size, by Material, 2025 vs 2032 (%)
FIGURE 11. Global Revascularization Device Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Revascularization Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Revascularization Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Revascularization Device Market Size, by Clinical Indication, 2025 vs 2032 (%)
FIGURE 15. Global Revascularization Device Market Size, by Clinical Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Revascularization Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Revascularization Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Revascularization Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Revascularization Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Revascularization Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Revascularization Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Revascularization Device Market Segmentation & Coverage
TABLE 2. Global Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Atherectomy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Atherectomy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Atherectomy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Balloon Angioplasty Catheters Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Balloon Angioplasty Catheters Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Balloon Angioplasty Catheters Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Bare-Metal Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Bare-Metal Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Bare-Metal Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Drug-Coated Balloons Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Drug-Coated Balloons Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Drug-Coated Balloons Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Drug-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Drug-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Drug-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Everolimus-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Everolimus-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Everolimus-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Paclitaxel-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Paclitaxel-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Paclitaxel-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Sirolimus-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Sirolimus-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Sirolimus-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Zotarolimus-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Zotarolimus-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Zotarolimus-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Vascular Scaffolds Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Vascular Scaffolds Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Vascular Scaffolds Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 35. Global Coronary Artery Bypass Grafting Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Coronary Artery Bypass Grafting Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Coronary Artery Bypass Grafting Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Percutaneous Coronary Intervention Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Percutaneous Coronary Intervention Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Percutaneous Coronary Intervention Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 42. Global Bioabsorbable Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Bioabsorbable Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Bioabsorbable Scaffold Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Metallic Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Metallic Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Metallic Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Cobalt-Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Cobalt-Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Cobalt-Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Platinum-Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Platinum-Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Platinum-Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Stainless Steel Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Stainless Steel Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Stainless Steel Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Bioresorbable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Bioresorbable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Bioresorbable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Non-Biodegradable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Non-Biodegradable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Non-Biodegradable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Specialty Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Specialty Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Specialty Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 77. Global Acute Coronary Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Acute Coronary Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Acute Coronary Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Restenosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Restenosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Restenosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Stable Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Stable Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Stable Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 96. North America Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. North America Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 98. North America Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 99. North America Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 100. North America Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 101. North America Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 102. North America Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 103. North America Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. North America Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 105. Latin America Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Latin America Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Latin America Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 108. Latin America Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 109. Latin America Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 110. Latin America Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 111. Latin America Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 112. Latin America Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Latin America Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 114. Europe Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Europe Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. Europe Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 117. Europe Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 118. Europe Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 119. Europe Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 120. Europe Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 121. Europe Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Europe Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 123. Middle East Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Middle East Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Middle East Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 126. Middle East Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 127. Middle East Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 128. Middle East Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 129. Middle East Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 130. Middle East Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Middle East Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 132. Africa Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Africa Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. Africa Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 135. Africa Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 136. Africa Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 137. Africa Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 138. Africa Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 139. Africa Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Africa Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 141. Global Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. ASEAN Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. ASEAN Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. ASEAN Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 145. ASEAN Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 146. ASEAN Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 147. ASEAN Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 148. ASEAN Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 149. ASEAN Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. ASEAN Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 151. GCC Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. GCC Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. GCC Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 154. GCC Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 155. GCC Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 156. GCC Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 157. GCC Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 158. GCC Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. GCC Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 160. European Union Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. European Union Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. European Union Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 163. European Union Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 164. European Union Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 165. European Union Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 166. European Union Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 167. European Union Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. European Union Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 169. BRICS Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. BRICS Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. BRICS Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 172. BRICS Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 173. BRICS Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 174. BRICS Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 175. BRICS Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 176. BRICS Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. BRICS Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 178. G7 Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. G7 Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 180. G7 Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 181. G7 Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 182. G7 Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 183. G7 Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 184. G7 Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 185. G7 Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. G7 Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 187. NATO Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. NATO Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. NATO Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 190. NATO Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 191. NATO Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 192. NATO Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 193. NATO Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 194. NATO Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. NATO Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 196. Global Revascularization Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 197. United States Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 198. United States Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. United States Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 200. United States Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 201. United States Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 202. United States Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 203. United States Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 204. United States Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. United States Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 206. Canada Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 207. Canada Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. Canada Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 209. Canada Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 210. Canada Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 211. Canada Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 212. Canada Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 213. Canada Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Canada Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 215. Mexico Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 216. Mexico Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. Mexico Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 218. Mexico Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 219. Mexico Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 220. Mexico Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 221. Mexico Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 222. Mexico Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Mexico Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 224. Brazil Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 225. Brazil Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Brazil Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 227. Brazil Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 228. Brazil Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 229. Brazil Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 230. Brazil Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 231. Brazil Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Brazil Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 233. United Kingdom Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 234. United Kingdom Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. United Kingdom Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 236. United Kingdom Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 237. United Kingdom Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 238. United Kingdom Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 239. United Kingdom Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 240. United Kingdom Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. United Kingdom Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 242. Germany Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 243. Germany Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. Germany Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 245. Germany Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 246. Germany Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 247. Germany Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 248. Germany Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 249. Germany Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Germany Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 251. France Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 252. France Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 253. France Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 254. France Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 255. France Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 256. France Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 257. France Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 258. France Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. France Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 260. Russia Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 261. Russia Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. Russia Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 263. Russia Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 264. Russia Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 265. Russia Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 266. Russia Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 267. Russia Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Russia Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 269. Italy Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 270. Italy Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. Italy Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 272. Italy Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 273. Italy Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 274. Italy Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 275. Italy Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 276. Italy Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Italy Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 278. Spain Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 279. Spain Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 280. Spain Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 281. Spain Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 282. Spain Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 283. Spain Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 284. Spain Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 285. Spain Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Spain Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 287. China Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 288. China Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. China Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 290. China Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 291. China Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 292. China Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 293. China Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 294. China Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. China Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 296. India Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 297. India Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. India Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 299. India Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 300. India Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 301. India Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 302. India Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 303. India Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. India Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 305. Japan Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 306. Japan Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 307. Japan Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 308. Japan Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 309. Japan Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 310. Japan Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 311. Japan Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 312. Japan Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Japan Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 314. Australia Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 315. Australia Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 316. Australia Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 317. Australia Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 318. Australia Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 319. Australia Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 320. Australia Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 321. Australia Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Australia Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 323. South Korea Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 324. South Korea Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 325. South Korea Revascularization Device Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 326. South Korea Revascularization Device Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 327. South Korea Revascularization Device Market Size, by Material, 2017-2032 (USD Million)
TABLE 328. South Korea Revascularization Device Market Size, by Metallic, 2017-2032 (USD Million)
TABLE 329. South Korea Revascularization Device Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 330. South Korea Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. South Korea Revascularization Device Market Size, by Clinical Indication, 2017-2032 (USD Million)
TABLE 332. Global Revascularization Device Market Share, by Key Player, 2025
TABLE 333. Global Revascularization Device Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Getinge AB
  • iVascular SLU
  • Johnson & Johnson
  • Lepu Medical Technology (Beijing) Co., Ltd
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Limited
  • Penumbra, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Related Topics

Related Reports

Nitinol Revascularization Device Market - Global Forecast 2026-2032 - Product Image

Nitinol Revascularization Device Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Coronary Artery Disease Treatment Devices Market - Global Forecast 2026-2032 - Product Image

Coronary Artery Disease Treatment Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Angioplasty Balloons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Angioplasty Balloons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Coronary Artery Bypass Graft Procedures Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Coronary Artery Bypass Graft Procedures Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Beating Heart Stabilizers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Beating Heart Stabilizers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From

About the Revascularization Device Market

The Revascularization Device market is a subset of the Cardiovascular Devices market, which includes products used to treat cardiovascular diseases. Revascularization Devices are used to restore blood flow to the heart, typically through the use of stents, balloons, and other devices. These devices are used to treat coronary artery disease, peripheral artery disease, and other conditions. Revascularization Devices are typically used in combination with other treatments, such as medications and lifestyle changes. The market is driven by the increasing prevalence of cardiovascular diseases, as well as technological advancements in the field. Some of the major companies in the Revascularization Device market include Abbott, Boston Scientific, Medtronic, Terumo, and B. Braun. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.